FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/21/2024
Back to search
Official data from USPTO
FOLDIKINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FOLDIKINE
ST13
US500000079366890Class
1, 5, 42
Filing
79366890
Registration
7334166
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
12/21/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
12/07/2022
Registration date
03/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2024
Last transaction
03/26/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
12
Owner location
ES
Examiner
MORRIS, KRISTINA
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA
Representatives
Stephanie N. Nikitenko IpHorgan Ltd
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Protein in raw material form for scientific and medical research; proteins for use in science; proteins for use in industry; proteins for use in the manufacture of cosmetics; biological preparations for industry and science; biological preparations for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for scientific useother than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for industrial useother than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for use in laboratoriesother than for medical or veterinary use; culture media for microbiology for scientific and research use; culture media of eukaryotic cellsin particularimmunelymphoid and myeloid cells for scientific and research use
Class 5
Pharmaceutical preparations for the treatment of immune-mediated diseases; veterinary preparations for the treatment of immune-mediated diseases; biological preparations for medical use for the treatment of immune-mediated diseases; biological preparations for veterinary purposes for the treatment of immune-mediated diseases; immunomodulators; immunosuppressants; immunostimulants; growth factorscell growth media for growing cells for medical or clinical use; cell survival factorsnamely cell growth media for growing cells for medical or clinical use; pharmaceutical and veterinary preparations for regulating the immune system; pharmaceutical and veterinary preparations for the treatment and/or prevention of diseases and disorders of the immune system or those affecting the immune system; regulatory proteins for medical and veterinary use in the nature of protein arrays for medical use and medical diagnosis purposes
Class 42
Scientific and technological servicesscientific research ; research and development of products; design and development of biologicalpharmaceutical and veterinary products; medicalpharmacological and veterinary research services; research related to molecular science; research and development services in immunology; research and development services in the field of immunohistology; research and development services with respect to immunomodulatory molecules; laboratory research services in relation to the production of immunomodulatory biological molecules and chimeras thereof; software design and development; informationadvisoryconsultancy relating to the aforesaid services
Publications
History of USPTO decisions and trademark events.
25 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
11/15/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
11/14/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/27/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/08/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/20/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/29/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/14/2023
RFNT
REFUSAL PROCESSED BY IB
10/25/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/03/2023
RFRR
REFUSAL PROCESSED BY MPU
10/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/21/2023
CNRT
NON-FINAL ACTION WRITTEN
09/20/2023
DOCK
ASSIGNED TO EXAMINER
09/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/06/2023
Continuous trademark protection
Get notified about every new filing that threatens FOLDIKINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.